Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion

International Journal of Cancer

Volumn 89, Issue 2, 2000, Pages 307-317

  O Charoenrat, Pornchai ^a,b   Rhys Evans, Peter ^a   Modjtahedi, Helmout ^c   Court, William ^b   Box, Gary ^b   Eccles, Suzanne ^b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; COLLAGENASE 3; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE A; GELATINASE B; MATRIGEL; STROMELYSIN; STROMELYSIN 2; STROMELYSIN 3;

ARTICLE; CANCER INVASION; CERVICAL LYMPH NODE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGAND BINDING; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; BIOSYNTHESIS; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK TUMOR; PATHOLOGY;

CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR CELLS, CULTURED;

EID: 0034181347     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(20000501)86:3<307::aid-ijc2>3.0.co;2-i     Document Type: Article

References (23)

1. ALBINI, A., IWAMOTO, Y., KLEINMAN, H.K., MARTIN, G.R., AARONSON, S.A., KOZLOWSKI, J.M. and MCEWAN, R.N., A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res., 47, 3239-3245 (1987).
2. ALMADORI, G., CADONI, G., GALLI, J., FERRANDINA, G., SCAMBIA, G., EXARCHAKOS, G., PALUDETTI, G. and OTTAVIANI, F., Epidermal growth factor receptor expression in primary laryngeal cancer: An independent prognostic factor of neck node relapse. Int. J. Cancer (Pred. Oncol.), 84, 188-191 (1999).
3. r72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res., 50, 6184-6191 (1990).
4. COWLEY, G.P., SMITH, J.A. and GUSTERSON, B. A., Increased EGF receptors on human squamous carcinoma cell lines. Br. J.Cancer, 53, 223-229 (1986).
5. DAMSTRUP, L., RUDE VOLDBORG, B., SPANG-THOMSEN, M., BRUNNER, N. and SKOVGAARD POULSEN, H., In vitro invasion of small-cell lung cancer cell lines correlates with expression of epidermal growth factor receptor. Br. J. Cancer. 78, 631-640 (1998).
6. ECCLES, S.A., MODJTAHEDI, H., BOX, G., COURT, W., SANDLE, J. and DEAN, C., Significance of the c-erbB family of receptor tyrosine kinases in metastatic cancer and their potential as targets for irnmunotherapy. Invasion Metastasis, 14, 337-348 (1994).
7. FERNANDEZ-RESA, P., MIRA, E. and QUESADA, A.R., Enhanced detection of casein zymography of matrix metallproteinases. Anal. Biochem., 224, 434-435 (1995).
8. GOLDBERG, G.I., STRONGIN, A., COLLIER, I.E., GENRICH, L.T. and MARMER, B.L., Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J. Biol. Chem., 267, 4583-4591 (1992).
9. GRANDIS, J.R., MELHEM, M.F., GOODING, W.E., DAY, R., HOLST, V.A., WAGENER, M.M., DRENNING, S.D. and TWEARDY, D.J., Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J. Natl. Cancer Inst., 90, 824-832 (1998).
10. GRANT, G.M., COBB, J.K., CASTILLO, B. and KLEBE, R.J. Regulation of matrix metalloproteinases following cellular transformation. J. Cell Physiol., 167, 177-183 (1996).
11. KLEINER, D.E. and STETLER-STEVENSON, W.G., Quantitative zymography: Detection of picogram quantities of gelatinases. Anal. Biochem., 218, 325-329 (1994).
12. MCDOUGALL, J.R. and MATRISIAN, L.M., Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev., 14, 351-362 (1995).
13. MODJTAHEDI, H., KOMURASAKI, T., TOYODA, H. and DEAN, C., Anti-EGFR monoclonal antibodies which act as EGF, TGFa, HB-EGF and BTC antagonists block the binding of epiregulin to EGFR-expressing tumors. Int. J. Cancer, 75, 310-316 (1998).
14. OLIVER, G.W., LEFERSON, J.D., STETLER-STEVENSON, W.G. and KLEINER, D.E., Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms. Anal. Biochem., 244, 161-166 (1997).
15. PYKE, C., RALFKIAER, E., HUHTALA, P., HURSKAINEN, T., DANO, K. and TRYGGVASON, K., Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancer by in situ hybridization. Cancer Res., 52, 1336-1341 (1992).
16. RAMOS-DESIMONE, N., MOLL, U.M., QUIGLEY, J.P. and FRENCH, D.L., Inhibition of matrix metalloproteinase activation by a specific monoclonal antibody. Hybridoma, 12, 349-363 (1993).
17. ROSENTHAL, E.L., JOHNSON, T.M., ALLEN, E.D., APEL, I.J., PUNTURIERI, A. and WEISS, S.J., Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells. Cancer Res., 58, 5221-5230 (1998).
18. SATO, H. and SEIKI, M., Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene, 8, 395-405 (1993).
19. THOMAS, G.T., LEWIS, M.P. and SPEIGHT, P.M., Matrix metalloproteinases and oral cancer. Oral Oncol., 35, 227-233 (1999).
20. UMENISHI, F., UMEDA, M. and MIYAZAKI, K., Efficient purification of TIMP-2 from culture medium conditioned by human hepatoma cell line, and its inhibitory effects on metalloproteinases and in vitro tumor invasion. J. Biochem., 110, 189-195 (1991).
21. VOKES, E.E., WEICHSELBAUM, R.R., LIPPMAN, S.M. and HONG, W.K., Head and neck cancer. N. Engl. J. Med., 328, 184-194 (1993).
22. XIE, H., TURNER, T., WANG, M.-H., SINGH, R.K., SIEGAL, G.P. and WELLS, A., in vitro and invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals. Clin. Exp. Metastasis, 13, 407-419 (1995).
23. XIE, W.Q. and ROTHBLUM, L.I., Rapid, small-scale RNA isolation from tissue culture cells. BioTechniques, 11(3), 325-327 (1991).